The Johns Hopkins ARVC program was established in 1999 with the goal of improving diagnosis and management of ARVC. Over the years, our program, in collaboration with others around the world, have gained a better understanding of the genetic influence, most appropriate cardiac testing tools, medications, treatment with catheter ablation and sympathectomy, predictors of arrhythmic events, role of exercise, and understanding overall psychosocial needs and adjustment. The Johns Hopkins ARVC Program hosts an annual conference for patients and families to learn the latest information on this rare inherited heart condition and to provide a platform for which they can meet others sharing similar stories. This conference is typically held in Baltimore, but due to the COVID-19 pandemic, this year's conference will be presented in an all virtual format. In an effort to take advantage of the virtual platform, we have invited ARVD/C experts from all over the world to share information they have contributed to the overall understanding of ARVD/C. You surely don't want to miss this opportunity to hear from the best! And it's FREE!